Effect of chronic treatment with milnacipran on sleep architecture in rats compared with paroxetine and imipramine

Pharmacology Biochemistry and Behavior

Volumn 73, Issue 3, 2002, Pages 557-563

  Gervasoni, D ^a   Panconi, E ^b   Henninot, V ^a   Boissard, R ^a   Barbagli, B ^a   Fort, P ^a   Luppi, P H ^a  

^a INSERM   (France)

^b INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

Chronic treatments; Frontal and occipital cortices; Imipramine; Milnacipran; Paroxetine; Rats; REM sleep; Slow wave sleep; Wakefulness

Indexed keywords

ANTIDEPRESSANT AGENT; IMIPRAMINE; MILNACIPRAN; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DELTA RHYTHM; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ELECTROENCEPHALOGRAM; GAMMA RHYTHM; LIGHT DARK CYCLE; MALE; NONHUMAN; POWER SPECTRUM; PRIORITY JOURNAL; RAT; REM SLEEP; SLOW WAVE SLEEP; THETA RHYTHM; WAKEFULNESS;

EID: 0036345488     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(02)00812-2     Document Type: Article

References (42)

1. Antidepressant properties of specific serotonin-noradrenaline reuptake inhibitors
2. The neuropharmacology of serotonin and noradrenaline in depression
3. Successful separation of depressed, normal, and insomniac subjects by EEG sleep data
4. Role of the locus coeruleus in the sleep rebound following two different sleep deprivation methods in the rat
5. Effects of serotonin and noradrenaline uptake blockers on wakefulness and sleep in cats
6. Imipramine and REM sleep: Cholinergic mediation in animals
7. Effect of two antidepressant drugs on REM sleep and EMG activity during sleep
8. The role of monoamines and acetylcholine-containing neurons in the regulation of the sleep-waking cycle
9. The effects of indalpine - A selective inhibitor of 5-HT uptake - On rat paradoxical sleep
10. Differential effects of three tricyclic antidepressants on sleep and REM sleep in the rat
11. Effects of the selective 5-hydroxytryptamine uptake inhibitors paroxetine and zimeldine on EEG sleep and waking stages in the rat
12. REM latency: A psychobiologic marker for primary depressive disease
13. Antidepressant effects of milnacipran in the learned helplessness test in rats
14. A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression
15. Effects of acute and chronic treatment with amoxapine and cericlamine on the sleep-wakefulness cycle in the rat
16. Venlafaxine occupation at the noradrenaline reuptake site: In-vivo determination in healthy volunteers
17. S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine
18. S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine
19. Effects of milnacipran and pindolol on extracellular noradrenalin and serotonin levels in guinea pig hypothalamus
20. Biochemical profile of midalcipran (F 2207), 1-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drug
21. Citalopram: Differential sleep/wake and EEG power spectrum effects after single dose and chronic administration
22. 5-Hydroxytryptamine and noradrenaline uptake inhibition: Studies on sleep in man
23. Effects of acute and chronic treatment with amitryptyline on the sleep-wake activity of rats
24. Short-term effects of fluoxetine and trifluoromethylphenylpiperazine on electroencephalographic sleep in the rat
25. Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: An overview of its antidepressant activity and clinical tolerability
26. The determination of the optimal dose of milnacipran in the olfactory bulbectomised rat model of depression
27. Analysis of sleep EEG microstructure in subchronic paroxetine treatment of healthy subjects
28. Executive mechanisms of paradoxical sleep
29. Effects of venlafaxine in the sleep architecture of rats
30. Sleep changes after 4 consecutive days of venlafaxine administration in normal volunteers
31. Conventional and spectral power analysis of all-night sleep EEG after subchronic treatment with paroxetine in healthy male volunteers
32. The effects of paroxetine and nefazodone on sleep: A placebo controlled trial
33. Chronic zimeldine administration to cats: Sustained increase of serotonergic effect as measured with sleep parameters
34. Behavioral, sleep-waking and EEG power spectral effects following the two specific 5-HT uptake inhibitors zimeldine and alaproclate in cats
35. Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression
36. Acute, subchronic and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: A double-blind randomized trial in major depression
37. Effects of fluoxetine on the polysomnogram in outpatients with major depression
38. The acute effects of the noradrenaline reuptake inhibitor Org 4428 on EEG sleep in healthy volunteers
39. Improvement of depression by REM sleep deprivation. New findings and a theory
40. Drug effects on REM sleep and on endogenous depression
41. The biological basis of an antidepressant response to sleep deprivation and relapse: Review and hypothesis
42. Effects of trazodone hydrochloride and imipramine on polysomnography in healthy subjects